Biotech

All Articles

Roche is holding out chances that its own injectable weight problems possibility can ultimately show 25% fat loss in late-stage trial

.Roche is holding out chances that its injectable obesity prospect could inevitably show 25% weight ...

Novo Nordisk hails 'exceptional' effective weight loss lead for dual-acting oral drug in very early trial

.Novo Nordisk has lifted the cover on a phase 1 trial of its dental amylin and GLP-1 receptor co-ago...

AbbVie files suit BeiGene over blood cancer cells drug classified information

.Merely a handful of quick full weeks after succeeding an FDA Fast Track tag for its own investigati...

Lilly provides one-two strike along with 2nd tranche of favorable information on weekly insulin prospect

.Not long after a positive information drop for Eli Lilly's efsitora alfa, the Indianapolis-based fi...

BridgeBio cuts genetics therapy spending plan as scientific data disappoint

.BridgeBio Pharma is actually slashing its genetics treatment budget and also drawing back from the ...

GSK relinquishes HSV vaccination wishes after stage 2 fall short, ceding race to Moderna, BioNTech

.GSK's attempt to develop the first injection for genital herpes simplex virus (HSV) has ended in br...

GSK's long-acting asthma drug cut in half strikes in stage 3

.GSK's long-acting asthma treatment has been shown to cut in half the amount of attacks in a pair of...

AstraZeneca, Daiichi unbox Dato-DXd's overall survival stop working

.AstraZeneca as well as Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has failed to ...

Roivant introduces brand new 'vant' to progress Bayer high blood pressure med

.Matt Gline is actually back along with a brand new 'vant' business, after the Roivant Sciences CEO ...

Viridian eye illness phase 3 hits, evolving push to competing Amgen

.Viridian Rehabs' stage 3 thyroid eye health condition (TED) medical test has actually attacked its ...